Randomised trial of paclitaxel in combination with platinum chemotherapy versus platinum-based chemotherapy in the treatment of relapsed ovarian cancer (ICON4/OVAR 2.2)

被引：0
|
作者：
Ledermann, JA [1 ]
机构：
[1] MRC, Clin Trials Unit, London NW1 2DA, England
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [1] Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer:: the ICON4/AGO-OVAR-2.2 trial
    Parmar, MKB
    Ledermann, JA
    Colombo, N
    du Bois, A
    Delaloye, JF
    Kristensen, GB
    Wheeler, S
    Swart, AM
    Qian, W
    Torri, V
    Floriani, I
    Jayson, G
    Lamont, A
    Tropé, C
    Lederman, JA
    Parmar, MKB
    Mangioni, C
    Torri, V
    Sandercock, J
    Dubois, A
    LANCET, 2003, 361 (9375): : 2099 - 2106
  • [2] Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (vol 361, pg 2099, 2003)
    Ledermann, JA
    Colombo, N
    du Bois, A
    Torri, V
    Floriani, I
    Qian, W
    Adams, HP
    Parmar, MKB
    Collins, S
    Wheeler, S
    Poli, D
    Santillo, M
    Buda, A
    Elser, G
    Schantl, P
    LANCET, 2003, 362 (9394): : 1504 - 1504
  • [3] BEVACIZUMAB AND PLATINUM-BASED CHEMOTHERAPY IN RELAPSED OVARIAN CANCER TREATMENT
    Davidenko, I.
    Kazantseva, M.
    Porhanova, N.
    Potemin, S.
    Oganyan, M.
    Syrota, L.
    Shmatkova, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [4] ICON1: A randomised trial of immediate platinum-based chemotherapy against chemotherapy delayed until indicated in women with ovarian cancer
    Guthrie, D
    BRITISH JOURNAL OF CANCER, 2001, 85 : 28 - 28
  • [5] Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial
    Blagden, Sarah P.
    Cook, Adrian D.
    Poole, Christopher
    Howells, Lesley
    McNeish, Ian A.
    Dean, Andrew
    Kim, Jae-Weon
    O'Donnell, Dearbhaile M.
    Hook, Jane
    James, Elizabeth C.
    White, Ian R.
    Perren, Timothy
    Lord, Rosemary
    Dark, Graham
    Earl, Helena M.
    Hall, Marcia
    Kaplan, Richard
    Ledermann, Jonathan A.
    Clamp, Andrew R.
    LANCET ONCOLOGY, 2020, 21 (07): : 969 - 977
  • [6] Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: A pilot study
    Kurtz, JE
    Deplanque, G
    Duclos, B
    Eichler, F
    Giron, C
    Limacher, JM
    Herbrecht, R
    Maloisel, F
    Oberling, F
    Bergerat, JP
    Dufour, P
    GYNECOLOGIC ONCOLOGY, 1998, 70 (03) : 414 - 417
  • [7] Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 273 - 274
  • [8] Is platinum-based chemotherapy with paclitaxel effective in optimally debulked patients with advanced ovarian cancer?
    Roovers, JPWR
    Sijmons, EA
    van Leeuwen, JHS
    Mol, BWJ
    Witteveen, PO
    Slee, PHTJ
    Heintz, APM
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 97 (01): : 80 - 84
  • [9] Platinum-based adjuvant chemotherapy for early-stage epithelial ovarian cancer: Single or combination chemotherapy?
    Adams, G.
    Zekri, J. M.
    Wong, H.
    Green, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Platinum-based adjuvant chemotherapy for early-stage epithelial ovarian cancer: single or combination chemotherapy?
    Adams, G.
    Zekri, J.
    Wong, H.
    Walking, J.
    Green, J. A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (12) : 1459 - 1467
12345